Delek Real Estate nears bondholders settlement

Bondholders are still deliberating, though, whether to accept or reject the offer.

By HILLEL KOREN
January 25, 2012 22:38
1 minute read.
The Jerusalem Post

yitzhak tshuva 311. (photo credit: Delek group via Bloomberg)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Trading in Delek Real Estate Ltd. shares was halted Wednesday morning following a report by the company that it will publish clarifications concerning negotiations with its bondholders.

Before trading was stopped, company share and bond prices had sharply risen in pretrading, as the company nears a settlement with its bondholders. However, the company subsequently issued a statement insisting that it has not yet reached agreement with bondholders.

Be the first to know - Join our Facebook page.


Over the last few days, Delek Real Estate controlling shareholder Yitzhak Tshuva has significantly increased his contribution to the company’s debt settlement. He said he is willing to inject NIS 500 million within nine years, to provide NIS 400m. in collateral for 16 years, and to forgive a NIS 83m. company debt due him for bonds that he holds.

Bondholders were requested to erase NIS 2.1 billion in bonds that they hold, and to receive in their place NIS 1.3b. worth of two new bond series. The granting of collateral is conditional upon the lending banks’ approval.

With respect to the flow of capital, Tshuva would be waiving NIS 1b. worth of bonds and collateral. Bondholders are still deliberating, though, whether to accept or reject the offer.

The company is simultaneously preparing to receive a negative answer from uninsured creditors, and has already completed the preparation of relevant legal documents needed to request a stay of proceedings from the court.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS